Just – Evotec Biologics awarded contract from U.S. Department of Defense under accelerated antibodies program
Just–Evotec Biologics will support the DOD with rapid, cost-efficient development of safe, efficacious anti-plague mabs. Evotec will provide pre-clinical and clinical trial services.